(Q40663728)

22 September 2017

title

Autoantibodies to oxidized low-density lipoprotein in patients with type 2 diabetes mellitus (English)

1 reference

22 September 2017

1 reference

1 reference

Rebecca M Hsu

1

1 reference

22 September 2017

Sridevi Devaraj

series ordinal

2

1 reference

22 September 2017

Ishwarlal Jialal

series ordinal

3

1 reference

22 September 2017

publication date

1 March 2002

1 reference

22 September 2017

1 reference

22 September 2017

volume

317

1 reference

22 September 2017

issue

1-2

1 reference

22 September 2017

page(s)

145-150

1 reference

Atherosclerosis — An Inflammatory Disease

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Oxidized low-density lipoprotein and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Role of oxidised low density lipoprotein in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Low density lipoprotein undergoes oxidative modification in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Low and very low density lipoprotein composition and resistance to copper-induced oxidation are not notably modified in smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900767-7

10.1016/S0009-8981(01)00767-7

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference